Submitted by Anonymous (not verified) on 13 October 2026 - 16:14
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 18, Status: Authorised